Oramed to Host Webinar Highlighting Detailed Safety and Efficacy Data from Its Positive Phase 2 Clinical Trial of ORMD-0801 for NASH
Stock Information for Oramed Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.